Incyte to Present at Upcoming Investor Conferences
18 Outubro 2023 - 9:00AM
Business Wire
Incyte (Nasdaq:INCY) announced today that it will present at the
following investor conferences during the month of November:
- Guggenheim Securities 5th Annual Inflammation, Neurology &
Immunology (INI) Conference on Tuesday, November 7, 2023 at 1:10 pm
(EST)
- Evercore ISI 6th Annual HealthCONx Conference on Thursday,
November 30, 2023 at 12:30 pm (EST)
The presentations will be webcast live and can be accessed at
Investor.Incyte.com and will be available for replay for 30
days.
About Incyte Incyte is a Wilmington, Delaware-based,
global biopharmaceutical company focused on finding solutions for
serious unmet medical needs through the discovery, development and
commercialization of proprietary therapeutics. For additional
information on Incyte, please visit Incyte.com and follow
@Incyte.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231018095054/en/
Incyte Media
media@incyte.com
Investors ir@incyte.com
Incyte (NASDAQ:INCY)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Incyte (NASDAQ:INCY)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
